TEVA PHARMACEUTICAL INDUSTRIES, LTD.
517Patents
246Active
517Granted
54Portfolio score
Filing activity: Nov 22, 1978 → May 7, 2023 · 172 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7056942B2 | Carvedilol | Human Necessities | 186 | Expired |
| US7195778B2 | Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery | Human Necessities | 146 | Expired |
| US5478564A | Preparation of microparticles for controlled release of water-soluble substances | Emerging Cross-Sectional Technologies | 92 | Expired |
| US5532415A | R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof | Chemistry; Metallurgy | 79 | Expired |
| US5519061A | R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof | Chemistry; Metallurgy | 78 | Expired |
| USD827127S1 | Injector pen | General | 68 | Active |
| US8598203B2 | Treatment of Crohn's disease with laquinimod | Chemistry; Metallurgy | 65 | Active |
| US5877218A | Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives | Chemistry; Metallurgy | 64 | Expired |
| US8663703B2 | Drug microparticles, processes of preparing them and a drug delivery vehicle comprising them | Performing Operations; Transporting | 63 | Active |
| US5486541A | Monofluorinated derivatives of N-propargyl-1-aminoindan and their use as inhibitors of monoamine oxidase | Chemistry; Metallurgy | 61 | Expired |
| US5840756A | Pharmaceutical composition of L-DOPA ester | Human Necessities | 60 | Expired |
| US5387612A | Use of the R-enantiomers of N-propargyl-1-aminoindan compounds for treating Parkinson's disease | Chemistry; Metallurgy | 55 | Expired |
| US5776445A | Ophthalmic delivery system | Human Necessities | 53 | Expired |
| US8591463B1 | Re-useable injector device for syringe | Human Necessities | 52 | Active |
| US5457133A | R-enantiomers of N-propargyl-aminoindan compounds, their preparation and pharmaceutical compositions containing them | Chemistry; Metallurgy | 52 | Expired |
| US5453446A | Use of the R-enantiomers of N-propargyl 1-aminoindan compounds for treating Parkinson's disease. | Chemistry; Metallurgy | 51 | Expired |
| US7033582B2 | Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders | Human Necessities | 49 | Expired |
| US5744500A | Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof | Chemistry; Metallurgy | 48 | Expired |
| US5576353A | Method of treating memory disorders using R-enantiomers of N-propargyl-aminoindan compounds | Chemistry; Metallurgy | 48 | Expired |
| USD660411S1 | Inhaler | General | 46 | Expired |
| US5786390A | Pharmaceutical compositions of the R-enantiomer of N-propargyl -1-aminoindan | Chemistry; Metallurgy | 45 | Expired |
| US5668181A | Use of the R-enantiomers of N-propargyl-1-aminoindan compounds for the treatment of depression | Chemistry; Metallurgy | 45 | Expired |
| US6316504A | Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof | Chemistry; Metallurgy | 45 | Expired |
| USD660410S1 | Inhaler | General | 44 | Expired |
| US5891923A | R-enantiomer of N-propargyl-1-aminoindan for the treatment of dementia | Chemistry; Metallurgy | 43 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.